Exzellenzstrategie

Pharmacological effectors of the SRF-TCF/MRTF transcriptional control module

Project description

The team of Prof. Alfred Nordheim (Molecular Biology, Interfaculty Institute of Cell Biology) has engaged with TÜCADD in the pursuit of two cancer drug development projects:

  1. “Identification of pharmacological effectors of the SRF-TCF/MRTF transcriptional control module“, and
  2. “Targeting mitochondrial metabolism in liver cancer”.

Status:

For both projects candidate molecular targets have been identified, functional assays of these targets have been established, and platforms for effector molecule screens are being developed.